This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 1999 Dec 9;341(24):1840-2.

doi: 10.1056/NEJM199912093412411.

Miltefosine--the long-awaited therapy for visceral leishmaniasis?

PMID: 10588972
DOI: 10.1056/NEJM199912093412411

Editorial

Miltefosine--the long-awaited therapy for visceral leishmaniasis?

B L Herwaldt. N Engl J Med. 1999.

. 1999 Dec 9;341(24):1840-2.

doi: 10.1056/NEJM199912093412411.

Author

PMID: 10588972
DOI: 10.1056/NEJM199912093412411

No abstract available

PubMed Disclaimer

Comment in

Miltefosine for visceral leishmaniasis.
Sherwood JA. Sherwood JA. N Engl J Med. 2000 Mar 23;342(12):895. doi: 10.1056/NEJM200003233421215. N Engl J Med. 2000. PMID: 10733377 No abstract available.

Comment on

Miltefosine, an oral agent, for the treatment of Indian visceral leishmaniasis.
Jha TK, Sundar S, Thakur CP, Bachmann P, Karbwang J, Fischer C, Voss A, Berman J. Jha TK, et al. N Engl J Med. 1999 Dec 9;341(24):1795-800. doi: 10.1056/NEJM199912093412403. N Engl J Med. 1999. PMID: 10588964 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.